1. Left Ventricular Hypertrophy

   • Daniel Levy

   Section 1: Cardiovascular Hypertrophy 18 October 2012 Pages: 1 - 5

2. Factors Involved in the Pathogenesis of Hypertensive Cardiovascular Hypertrophy

   • Björn Dahlöf

   Section 1: Cardiovascular Hypertrophy 18 October 2012 Pages: 6 - 26

3. Left Ventricular Hypertrophy and Antihypertensive Therapy

   • Franz H. Messerli
   • Shmuel Oren
   • Ehud Grossman

   Section 1: Cardiovascular Hypertrophy 18 October 2012 Pages: 27 - 33

4. Heterogeneity of Response of Peripheral Arteries to Antihypertensive Drugs in Essential Hypertension

   • Jaime Levenson
   • Alain Simon

   Section 1: Cardiovascular Hypertrophy 18 October 2012 Pages: 34 - 39

5. Panel Discussion Session 1

   • L. Hansson

   Announcement 18 October 2012 Pages: 40 - 41

6. Aspects of the Role of Intraglomerular Pressure as a Cause of Progressive Renal Damage

   • Mattias Aurell

   Section 2: The Pathogenic Role of the Kidney 18 October 2012 Pages: 42 - 47

7. Proteinuria as a Prognostic Factor during Long Term Hypertensive Care

   • O. Samuelsson

   Section 2: The Pathogenic Role of the Kidney 18 October 2012 Pages: 48 - 54

8. Renal Function before and after Withdrawal of Long Term Antihypertensive Treatment in Primary Hypertension

   • Susanne Ljungman
   • Mattias Aurell
   • Göran Berglund

   Section 2: The Pathogenic Role of the Kidney 18 October 2012 Pages: 55 - 58

9. Effects of Antihypertensive Therapy on Kidney Function in Diabetic Patients

   • Bengt Scherstén

   Section 2: The Pathogenic Role of the Kidney 18 October 2012 Pages: 59 - 61

10. Renal Protective Effect of Long Term Antihypertensive Therapy with Enalapril

    • John H. Bauer
    • Garry P. Reams

    Section 2: The Pathogenic Role of the Kidney 18 October 2012 Pages: 62 - 71

11. Panel Discussion Session 2

    • M. Aurell

    Announcement 18 October 2012 Pages: 72 - 73

12. Quality of Life under Antihypertensive Treatment

    • James A. Schoenberger

    Section 3: Quality of Life 18 October 2012 Pages: 74 - 79

13. Memory Function — Effects of Different Antihypertensive Drugs

    • P. J. Richardson
    • M. A. Wyke

    Section 3: Quality of Life 18 October 2012 Pages: 80 - 85

14. Evaluation of Mood and the Effect of Angiotensin-Converting Enzyme Inhibitors

    • Sverker Jern

    Section 3: Quality of Life 18 October 2012 Pages: 86 - 88

15. Safety Profiles of the Angiotensin-Converting Enzyme Inhibitors

    • Natalie J. Warner
    • Janet E. Rush

    Section 3: Quality of Life 18 October 2012 Pages: 89 - 97

16. Panel Discussion Session 3

    • L. Hansson

    Announcement 18 October 2012 Pages: 98 - 99

17. Closing Remarks

    • L. Hansson

    OriginalPaper 18 October 2012 Pages: 100 - 101